Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.
Forge Biologics has raised $90.0M in total funding. The most recent round was Series C. The last funding was announced in September 2022.
Forge Biologics's investors include RA Capital Management, Perceptive Advisors, MidCap Financial, Drive Capital, Octagon Capital Advisors.
Forge Biologics is headquartered in Grove City, United States.
Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.
Forge Biologics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Forge Biologics — Funding & Investors." VCBacked, September 12, 2022, https://www.vcbacked.co/company/forge-biologics. Accessed August 15, 2026.
VCBacked. (2022). Forge Biologics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/forge-biologics
{{cite web |title=Forge Biologics — Funding & Investors |url=https://www.vcbacked.co/company/forge-biologics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated